469. Deputy Denis Naughten asked the Minister for Health further to Parliamentary Question No. 258 of 11 May 2022, when the HSE will approve the reimbursement under the high-tech drug arrangements for kaftrio for children under 12 years of age; the reason for the delay in approval in view of the fact that it has already been approved for children aged 12 years and over; the steps taken by the HSE to consider this dossier; the dates on which these steps were taken; if all outstanding queries have been addressed by the applicant company; if so, when; and if he will make a statement on the matter. [44404/22]

Summary

469. Deputy Denis Naughten asked the Minister for Health further to Parliamentary Question No. 258 of 11 May 2022, when the HSE will approve the reimbursement under the high-tech drug arrangements for kaftrio for children under 12 years of age; the reason for the delay in approval in view of the fact that it has already been approved for children aged 12 years and over; the steps taken by the HSE to consider this dossier; the dates on which these steps were taken; if all outstanding queries have been addressed by the applicant company; if so, when; and if he will make a statement on the matter. [44404/22]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products

  xml · EN · 14 September 2022

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.